Relay Therapeutics, Inc. (RLAY) ownership: Top institutional holder: SB INVESTMENT ADVISERS (UK) LTD ($277.65M). Insider activity: Net Seller (0 buys, 9 sells). 1 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 27904963.00 | $277.65M | 2026-03-31 |
| Commodore Capital LP | 17000000.00 | $169.15M | 2026-03-31 |
| Casdin Capital, LLC | 14418574.00 | $143.46M | 2026-03-31 |
| BlackRock, Inc. | 12975299.00 | $129.10M | 2026-03-31 |
| Point72 Asset Management, L.P. | 13859172.00 | $117.25M | 2025-12-31 |
| PERCEPTIVE ADVISORS LLC | 9751141.00 | $97.02M | 2026-03-31 |
| VANGUARD GROUP INC | 9691445.00 | $81.99M | 2025-12-31 |
| Bellevue Group AG | 7795242.00 | $77.56M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-14 | |
| Sell | null | 2026-04-28 | |
| Sell | null | 2026-04-28 | |
| Sell | null | 2026-04-28 | |
| Sell | null | 2026-04-09 | |
| Sell | null | 2026-04-09 | |
| Sell | null | 2026-04-09 | |
| Sell | null | 2026-04-07 |
Back to RLAY overview · RLAY earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.